In this regard, we have recently demonstrated that MEK5 and ERK5 are overexpressed in human colon adenomas and adenocarcinomas, suggesting that MEK5/ERK5 signaling overactivation may be involved in tumor initiation and progression [11]. Here, MAP2K5 is linked to neoplasm.